INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.400
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
INmune Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 33.55 | 35.85 | 52.15 | 74.81 | 21.97 | 7 | Upgrade
|
Cash & Short-Term Investments | 33.55 | 35.85 | 52.15 | 74.81 | 21.97 | 7 | Upgrade
|
Cash Growth | -19.76% | -31.26% | -30.29% | 240.56% | 214.02% | 3656.91% | Upgrade
|
Other Receivables | 1.42 | 2.44 | 8.46 | 5.5 | 1.8 | 0.65 | Upgrade
|
Receivables | 1.42 | 2.44 | 8.46 | 5.5 | 1.8 | 0.65 | Upgrade
|
Prepaid Expenses | 0.88 | 1.65 | 4.06 | 2.29 | 0.22 | 0.12 | Upgrade
|
Total Current Assets | 35.85 | 39.94 | 64.68 | 82.61 | 23.99 | 7.76 | Upgrade
|
Property, Plant & Equipment | 0.34 | 0.41 | 0.51 | 0.73 | 0.16 | 0.19 | Upgrade
|
Other Intangible Assets | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | Upgrade
|
Other Long-Term Assets | 0.08 | 0.13 | 0.1 | 0.1 | - | - | Upgrade
|
Total Assets | 52.78 | 57 | 81.8 | 99.95 | 40.66 | 24.47 | Upgrade
|
Accounts Payable | 10.59 | 7.9 | 5.21 | 3.8 | 1.52 | 0.4 | Upgrade
|
Accrued Expenses | 0.06 | 0.04 | 0.01 | 0.01 | 0.03 | 0.29 | Upgrade
|
Current Portion of Long-Term Debt | 2.49 | 9.92 | 5 | - | - | - | Upgrade
|
Current Portion of Leases | 0.14 | 0.12 | 0.09 | 0.07 | 0.03 | 0.01 | Upgrade
|
Other Current Liabilities | 0.55 | 0.49 | 0.62 | 0.47 | 0.19 | - | Upgrade
|
Total Current Liabilities | 13.82 | 18.47 | 10.92 | 4.36 | 1.78 | 0.7 | Upgrade
|
Long-Term Debt | - | - | 9.7 | 14.46 | - | - | Upgrade
|
Long-Term Leases | 0.28 | 0.4 | 0.53 | 0.7 | 0.13 | 0.16 | Upgrade
|
Other Long-Term Liabilities | - | - | 0.55 | 0.2 | - | - | Upgrade
|
Total Liabilities | 14.11 | 18.86 | 21.69 | 19.72 | 1.9 | 0.86 | Upgrade
|
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 193.58 | 159.14 | 151.8 | 143.92 | 72.11 | 44.83 | Upgrade
|
Retained Earnings | -153.89 | -121.02 | -91.01 | -63.72 | -33.38 | -21.28 | Upgrade
|
Comprehensive Income & Other | -1.04 | -0.8 | -0.7 | 0 | 0.01 | 0.04 | Upgrade
|
Total Common Equity | 38.68 | 37.34 | 60.1 | 80.23 | 38.75 | 23.61 | Upgrade
|
Shareholders' Equity | 38.68 | 38.14 | 60.1 | 80.23 | 38.75 | 23.61 | Upgrade
|
Total Liabilities & Equity | 52.78 | 57 | 81.8 | 99.95 | 40.66 | 24.47 | Upgrade
|
Total Debt | 2.91 | 10.44 | 15.31 | 15.23 | 0.16 | 0.17 | Upgrade
|
Net Cash (Debt) | 30.64 | 25.41 | 36.84 | 59.58 | 21.81 | 6.83 | Upgrade
|
Net Cash Growth | 6.01% | -31.03% | -38.16% | 173.20% | 219.42% | 3566.45% | Upgrade
|
Net Cash Per Share | 1.62 | 1.41 | 2.06 | 3.69 | 1.82 | 0.66 | Upgrade
|
Filing Date Shares Outstanding | 22.17 | 17.95 | 17.95 | 17.86 | 14.93 | 10.75 | Upgrade
|
Total Common Shares Outstanding | 22.17 | 17.95 | 17.95 | 17.84 | 13.48 | 10.77 | Upgrade
|
Working Capital | 22.03 | 21.48 | 53.76 | 78.25 | 22.21 | 7.06 | Upgrade
|
Book Value Per Share | 1.74 | 2.08 | 3.35 | 4.50 | 2.87 | 2.19 | Upgrade
|
Tangible Book Value | 22.16 | 20.83 | 43.59 | 63.71 | 22.24 | 7.1 | Upgrade
|
Tangible Book Value Per Share | 1.00 | 1.16 | 2.43 | 3.57 | 1.65 | 0.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.